Compositions and methods for detecting markers associated with bladder cancer
Abstract:
Compositions and methods for detecting bladder cancer are provided. In some embodiments, methods of monitoring recurrence of bladder cancer are provided. In some embodiments, the methods comprise detecting a set of markers consisting of CRH, IGF2, KRT20, and ANXA10.
Public/Granted literature
Information query
Patent Agency Ranking
0/0